No abstract available
Publication types
-
Consensus Development Conference
MeSH terms
-
Administration, Cutaneous
-
Administration, Sublingual
-
Anti-Asthmatic Agents / therapeutic use
-
Antibodies, Anti-Idiotypic
-
Antibodies, Monoclonal / therapeutic use
-
Antibodies, Monoclonal, Humanized
-
Asthma / therapy*
-
Clinical Trials as Topic
-
Desensitization, Immunologic / methods*
-
Humans
-
Omalizumab
-
Practice Guidelines as Topic
-
Quality of Life
-
Rhinitis, Allergic, Perennial / therapy
-
Treatment Outcome
Substances
-
Anti-Asthmatic Agents
-
Antibodies, Anti-Idiotypic
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Omalizumab